Our current research projects include:


  • Development of targeted therapeutics for primary and metastatic brain cancer
  • Development of targeted therapeutics for selected non-CNS cancers (e.g., breast)
  • Drug delivery augmentation using Convection Enhanced Delivery (CED; for brain cancer) and Focused Ultrasound (FUS; for brain and non-CNS cancers) 
  • Metabolic imaging of brain tumor progression and therapeutic responses
  • Expanding representative models of human glioma using genetically engineered mice and patient-derived cells with comprehensive molecular profiling data
The TTRG is a multi-disciplinary team of clinicians, engineers, and cancer biologists actively working together to solve life-limiting treatment challenges in the neuroscience and cancer fields.
Translational Therapeutics Research Group (TTRG) at the University of Maryland School of Medicine


Translational Therapeutics Research Group

Department of Neurosurgery

Brain Tumor Treatment & Research Center

NCI-Greenebaum Comprehensive Cancer Center

University of Maryland School of Medicine​ - Baltimore, MD

Collaborations: